Beijing KEY-BIO Biotech Co.,Ltd.was founded in 2007，as a national high-tech enterprise，is a supplier and service provider focusing on the systematic research of active raw materials of in vitro diagnostic reagents. The company covers an area of 2,400 square meters. Since 2016, it has been rated as a national high-tech enterprise. In 2017, it passed the ISO9001 quality management system certification, ISO14001 environmental management system certification, ISO45001 Occupational health management system certification, and intellectual property management system certification. The "double independent enterprise" identified by the Beijing Municipal Commission of Commerce has been awarded the honorary title of Beijing Specialized and special new "Little Giant" enterprise and national specialized and special new "Little Giant" enterprise in 2022, and has been successively selected as the Zhongguancun high-growth TOOP100 enterprise in 2021 and 2022, and won the Beijing Enterprise Innovation Credit Leader Certificate in 2022. At present, the company has 25 authorized invention patents, 1 utility model patent, and 17 registered trademarks. There are more than 20 research projects, and it has been rated as "Tax credit A-level enterprise" for more than 8 consecutive years.

KEY-BIO products mainly include infectious diseases, gonadal hormone, thyroid hormone, tumor markers, cytokines, heart and kidney diseases for the detection of antigens and antibodies and marker materials.  A large number of products are mature used in ELISA, plate chemiluminescence, magnetic particle-ALP chemiluminescence, magnetic particle-acridine esterification chemiluminescence, immunochromatography, microfluidic, biochemical turbidity and other platforms. On the basis of absorbing advanced technology and process at home and abroad, KEY-BIO constantly develops new products and high-quality products with years of practical experience, aiming to provide source power for the research in the field of human life science.  

KEY-BIO now has technical platforms such as gene engineering, protein engineering, antibody engineering and labeled immunoassay.  Using sufficient technical force and perfect r & D and production equipment, systematically carry out the research and development of biological active raw materials - intermediates - reagents.  

KEY-BIO adheres to the concept of "help science and technology leap to become China’s model, and on the basis of adhering to technological innovation, strictly focuses on quality management, constantly improves the technical level, and realizes the benign development of the company's business.  Now, KEY-BIO marketing network not only covers the whole country, but also sells to the international market.

In the future, KEY-BIO will continue to be committed to leading the research and development of first-class active protein antigens and antibodies to meet the challenges in the global biotechnology field.